High rates of multidrug resistance in Enterococcus faecalis and E. faecium isolated from inpatients and outpatients in Taiwan

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 4, 2013, Pages 406-411

  Wang, Jann Tay ^a,b,c   Chang, Shan Chwen ^a,b   Wang, Hui Yin ^c   Chen, Pei Chen ^c   Shiau, Yih Ru ^c   Lauderdale, Tsai Ling ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Antimicrobial resistance; Enterococcus faecalis; Enterococcus faecium; Multidrug resistance; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; NITROFURANTOIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GEOGRAPHY; HOSPITAL PATIENT; INTENSIVE CARE UNIT; LONGITUDINAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INPATIENTS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PREVALENCE; TAIWAN;

EID: 84875261426     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.01.004     Document Type: Article

References (32)

1. Arias C.A., Contreras G.A., Murray B.E. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 2010, 16:555-562.
2. Arias C.A., Murray B.E. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012, 10:266-278.
3. Chen F.J., Huang I.W., Wang C.H., Chen P.C., Wang H.Y., Lai J.F., et al. mecA-positive Staphylococcus aureus with low-level oxacillin MIC in Taiwan. J Clin Microbiol 2012, 50:1679-1683.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; twentieth information supplement. CLSI document (M100-S20) 2010, CLSI, Wayne, PA.
5. de Fatima Silva Lopes M., Ribeiro T., Abrantes M., Figueiredo Marques J.J., Tenreiro R., Crespo M.T. Antimicrobial resistance profiles of dairy and clinical isolates and type strains of enterococci. Int J Food Microbiol 2005, 103:191-198.
6. Ghanem G., Hachem R., Jiang Y., Chemaly R.F., Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 2007, 28:1054-1059.
7. Hammerum A.M. Enterococci of animal origin and their significance for public health. Clin Microbiol Infect 2012, 18:619-625.
8. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
9. Ho M., Hsiung C.A., Yu H.T., Chi C.L., Chang H.J. Changes before and after a policy to restrict antimicrobial usage in upper respiratory infections in Taiwan. Int J Antimicrob Agents 2004, 23:438-445.
10. Jean S.S., Hsueh P.R. Antimicrobial drug resistance in Taiwan. J Formos Med Assoc 2011, 110:4-13.
11. Jones R.N., Marshall S.A., Pfaller M.A., Wilke W.W., Hollis R.J., Erwin M.E., et al. Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 1997, 29:95-102.
12. King E.A., McCoy D., Desai S., Nyirenda T., Bicking K. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?. J Antimicrob Chemother 2011, 66:2112-2118.
13. Kuch A., Willems R.J., Werner G., Coque T.M., Hammerum A.M., Sundsfjord A., et al. Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. J Antimicrob Chemother 2012, 67:551-558.
14. Kuo S.C., Chang S.C., Wang H.Y., Lai H.F., Chen P.C., Shiau Y.R., et al. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infect Dis 2012, 12:200.
15. Lauderdale T.L., Shiau Y.R., Wang H.Y., Lai J.F., Huang I.W., Chen P.C., et al. Effect of banning vancomycin analogue avoparcin on vancomycin-resistant enterococci in chicken farms in Taiwan. Envi Microbiol 2007, 9:819-823.
16. Laupland K.B., Ross T., Pitout J.D., Church D.L., Gregson D.B. Community-onset urinary tract infections: a population-based assessment. Infection 2007, 35:150-153.
17. Leavis H.L., Bonten M.J., Willems R.J. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006, 9:454-460.
18. Lee S.J., Lee D.S., Choe H.S., Shim B.S., Kim C.S., Kim M.E., et al. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System. J Infect Chemother 2011, 17:440-446.
19. Lester C.H., Sandvang D., Olsen S.S., Schonheyder H.C., Jarlov J.O., Bangsborg J., et al. Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother 2008, 62:1203-1206.
20. Liu Y.C., Huang W.K., Huang T.S., Kunin C.M. Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan. Arch Intern Med 2001, 161:2366-2370.
21. Lodise T.P., McKinnon P.S., Tam V.H., Rybak M.J. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002, 34:922-929.
22. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
23. McDonald L.C., Chen M.T., Lauderdale T.L., Ho M. The use of antibiotics critical to human medicine in food-producing animals in Taiwan. J Microbio Immuno Infect 2001, 34:97-102.
24. McDonald L.C., Lauderdale T.L., Shiau Y.R., Chen P.C., Lai J.F., Wang H.Y., et al. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents 2004, 23:362-370.
25. O'Brien T.F., Stelling J. Integrated multilevel surveillance of the world's infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev 2011, 24:281-295.
26. Sader H.S., Jones R.N. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn Microbiol Infect Dis 2009, 65:158-162.
27. Sader H.S., Moet G.J., Farrell D.J., Jones R.N. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Diagn Microbiol Infect Dis 2011, 70:412-416.
28. Su C.H., Wang J.T., Hsiung C.A., Chien L.J., Chi C.L., Yu H.T., et al. Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 2012, 7:e37788.
29. Teixeira L.M., Carvalho G.S., Facklam R.R. Enterococcus. Manual of Clinical Microbiology 2007, 430-442. American Society for Microbiology, Washington, D.C. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, M.A. Pfaller (Eds.).
30. Wang J.T., Chen Y.C., Chang S.C., Chen M.L., Pan H.J., Chang Y.Y., et al. Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital. J Hosp Infect 2004, 58:97-103.
31. Willems R.J., Bonten M.J. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity. Curr Opin Infect Dis 2007, 20:384-390.
32. Willems R.J., van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol 2009, 4:1125-1135.